Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

CVS Health said it plans to allocate $20 billion over the next decade to streamline the US health system. The initiative aims ...

Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...

CVS Caremark is the largest PBM in the U.S., accounting for 33% of all prescriptions filled nationally. CVS denies the allegations.

CVS taps Ed DeVaney to head Caremark DeVaney was named president of the pharmacy benefit manager after serving in the interim role since December. Published Feb. 19, 2025 Emily Olsen Reporter ...

In 2012, CVS Caremark's Part D share has grown by 2.1 million persons enrolled, primarily due to the contracts with Universal American and HealthNet, plus organic growth of 207K enrolled.

Antoinette Alexander 1/12/2012 WOONSOCKET, R.I. — CVS Caremark announced on Thursday that the Federal Trade Commission has concluded its investigation into the company’s business practices.

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.